FDA gives rejected drugs another chance in post-Makary era

June 17, 2026 02:44 PM EDT FDA+ Af­ter Makary's ex­it, FDA is giv­ing CRL re­cip­i­ents an­oth­er chance Zachary Brennan Senior Editor Did you re­ceive a com­plete re­sponse let­ter in the past year? Now may be the time for a re­sub­mis­sion. In the wake of FDA Com­mis­sion­er … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER